Aug. 11 at 12:25 PM
$CBT earnings beat but sales miss — what's the real story? 🤔
Adjusted EPS of
$1.90 topped the Zacks Consensus Estimate of
$1.80, but net sales fell around 9.2% from the prior-year quarter, missing estimates. Reinforcement Materials sales dropped 11.7%, while Performance Chemicals EBIT rose 3.6% despite lower volumes.
Understand the full picture here 👉 https://www.zacks.com/stock/news/2696732/cabots-earnings-top-estimates-in-q3-sales-miss-on-lower-volumes?cid=sm-stocktwits-2-2696732-body-7059&ADID=SYND_STOCKTWITS_TWEET_2_2696732_BODY_7059